Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F U Nielsen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Urology and Nephrology|January 1, 1973
The flow capacity of ureteric cathetersF U Nielsen, E Thybo
Ugeskrift for Laeger|June 4, 1979
[Consciousness disorders with inappropriate ADH-secretion (inappropriate antidiuretic hormone secretion, SIADH or Schwartz-Bartter syndrome)]P Sehested, O Kristensen, F U Nielsen
Ugeskrift for Laeger|February 2, 1981
[Hypersedimentation of unknown origin. A follow-up study]S Antonsen, I R Hansen, F U Nielsen
Scandinavian Journal of Urology and Nephrology|March 6, 1975
Renal transplantation in patients with insulin requiring diabetes and renal failureP Thayssen, K Roed-Petersen, F U Nielsen, et al.
Scandinavian Journal of Urology and Nephrology|March 6, 1975
Dialysis therapy of terminal uraemia in insulin-requiring diabetic patientsK Roed-Petersen, P Thayssen, F U Nielsen, et al.
Acta Medica Scandinavica|January 1, 1977
The treatment of end-stage renal failure in insulin-dependent diabetic patientsP Thayssen, K Roed-Petersen, F U Nielsen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRIR J Maxwell, F U Nielsen, T Breidahl, et al.
NMR in Biomedicine|July 28, 1999
Localized in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reductionF U Nielsen, S Topp, M R Horsman, et al.
Cancer Research|June 30, 2001
Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopyF U Nielsen, P Daugaard, L Bentzen, et al.
Advances in Experimental Medicine and Biology|August 19, 2000
Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapyM R Horsman, R Murata, T Breidahl, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Urology and Nephrology|January 1, 1973
The flow capacity of ureteric cathetersF U Nielsen, E Thybo
Ugeskrift for Laeger|June 4, 1979
[Consciousness disorders with inappropriate ADH-secretion (inappropriate antidiuretic hormone secretion, SIADH or Schwartz-Bartter syndrome)]P Sehested, O Kristensen, F U Nielsen
Ugeskrift for Laeger|February 2, 1981
[Hypersedimentation of unknown origin. A follow-up study]S Antonsen, I R Hansen, F U Nielsen
Scandinavian Journal of Urology and Nephrology|March 6, 1975
Renal transplantation in patients with insulin requiring diabetes and renal failureP Thayssen, K Roed-Petersen, F U Nielsen, et al.
Scandinavian Journal of Urology and Nephrology|March 6, 1975
Dialysis therapy of terminal uraemia in insulin-requiring diabetic patientsK Roed-Petersen, P Thayssen, F U Nielsen, et al.
Acta Medica Scandinavica|January 1, 1977
The treatment of end-stage renal failure in insulin-dependent diabetic patientsP Thayssen, K Roed-Petersen, F U Nielsen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRIR J Maxwell, F U Nielsen, T Breidahl, et al.
NMR in Biomedicine|July 28, 1999
Localized in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reductionF U Nielsen, S Topp, M R Horsman, et al.
Cancer Research|June 30, 2001
Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopyF U Nielsen, P Daugaard, L Bentzen, et al.
Advances in Experimental Medicine and Biology|August 19, 2000
Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapyM R Horsman, R Murata, T Breidahl, et al.
Pageof 2